Identifying the Anti-Cancer Effect of Indigo Naturalis in Small Cell Lung Cancer Based on Network Pharmacological Analysis
![]() |
Young Hoon, Kim
(School of Korean Medicine, Pusan National University)
Woo Jin, Jeong (School of Korean Medicine, Pusan National University) Gwang Hee, Jeong (School of Korean Medicine, Pusan National University) Youn Sook, Kim (Research Institute for Longevity and Well-Being, Pusan National University) Won Gun, An (School of Korean Medicine, Pusan National University) |
1 | Chen DL, Zhou D, Chu W, Herrbrich P, Engle JT, Griffin E, et al. Radiolabeled isatin binding to caspase-3 activation induced by anti-Fas antibody. Nucl Med Biol. 2012;39(1):137-44. DOI |
2 | Ferraz de Paiva RE, Vieira EG, Rodrigues da Silva D, Wegermann CA, Costa Ferreira AM. Anticancer Compounds Based on Isatin-Derivatives: Strategies to Ameliorate Selectivity and Efficiency. Front Mol Biosci. 2020;7:627272:1-24. DOI |
3 | Jahng Y. Progress in the studies on tryptanthrin, an alkaloid of history. Arch Pharm Res. 2013;36(5):517-35. DOI |
4 | Yuan M, Zhao Y, Arkenau HT, Lao T, Chu L, Xu Q. Signal pathways and precision therapy of small-cell lung cancer. Signal Transduct Target Ther. 2022;7(1):187:1-18. DOI |
5 | Tsujimoto Y, Finger LR, Yunis J, Nowell PC, Croce CM. Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation. Science. 1984;226(4678):1097-9. DOI |
6 | Wang C, Zhang J, Yin J, Gan Y, Xu S, Gu Y, et al. Alternative approaches to target Myc for cancer treatment. Signal Transduct Target Ther. 2021;6(1):117:1-14. DOI |
7 | Baugh EH, Ke H, Levine AJ, Bonneau RA, Chan CS. Why are there hotspot mutations in the TP53 gene in human cancers? Cell Death Differ. 2018;25(1):154-60. DOI |
8 | George J, Lim JS, Jang SJ, Cun Y, Ozretic L, Kong G, et al. Comprehensive genomic profiles of small cell lung cancer. Nature. 2015;524(7563):47-53. DOI |
9 | el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, et al. WAF1, a potential mediator of p53 tumor suppression. Cell. 1993;75(4):817-25. DOI |
10 | Karimian A, Ahmadi Y, Yousefi B. Multiple functions of p21 in cell cycle, apoptosis and transcriptional regulation after DNA damage. DNA Repair (Amst). 2016;42:63-71. DOI |
11 | Peng H, Yuan X, Shi R, Wei X, Ren S, Yan C, et al. PHII-7 inhibits cell growth and induces apoptosis in leukemia cell line K562 as well as its MDR- counterpart K562/A02 through producing reactive oxygen species. Eur J Pharmacol. 2013;718(1-3):459-68. DOI |
12 | International Agency for Research on Cancer. Global Cancer Observatory: Cancer Today. Available from: https://gco.iarc.fr/today/fact-sheets-cancers [Accessed 28th September 2022]. |
13 | Byers LA, Rudin CM. Small cell lung cancer: where do we go from here? Cancer. 2015;121(5):664-72. DOI |
14 | Herzog BH, Devarakonda S, Govindan R. Overcoming Chemotherapy Resistance in SCLC. J Thorac Oncol. 2021;16(12):2002-15. DOI |
15 | Rudin CM, Brambilla E, Faivre-Finn C, Sage J. Small-cell lung cancer. Nat Rev Dis Primers. 2021;7(1):1-20. DOI |
16 | Minami T, Kijima T, Kohmo S, Arase H, Otani Y, Nagatomo I, et al. Overcoming chemoresistance of small-cell lung cancer through stepwise HER2-targeted antibody-dependent cell-mediated cytotoxicity and VEGF-targeted antiangiogenesis. Sci Rep. 2013;3:2669:1-11. |
17 | Quaresma M, Coleman MP, Rachet B. 40-year trends in an index of survival for all cancers combined and survival adjusted for age and sex for each cancer in England and Wales, 1971-2011: a population-based study. Lancet. 2015;385(9974):1206-18. DOI |
18 | Karachaliou N, Pilotto S, Lazzari C, Bria E, de Marinis F, Rosell R. Cellular and molecular biology of small cell lung cancer: an overview. Transl Lung Cancer Res. 2016;5(1):2-15. |
19 | Cancer.Net Editorial Board. Lung cancer - small cell - statistics. Available from: https://www.cancer.net/cancer-types/lung-cancer-small-cell/statistics [Accessed 28th September 2022]. |
20 | Pezzani R, Salehi B, Vitalini S, Iriti M, Zuniga FA, Sharifi-Rad J, et al. Synergistic Effects of Plant Derivatives and Conventional Chemotherapeutic Agents: An Update on the Cancer Perspective. Medicina (Kaunas). 2019;55(4):1-16. |
21 | Castaneda AM, Melendez CM, Uribe D, Pedroza-Diaz J. Synergistic effects of natural compounds and conventional chemotherapeutic agents: recent insights for the development of cancer treatment strategies. Heliyon. 2022;8(6):e09519. |
22 | Liu Z, Ma L, Zhou GB. The main anticancer bullets of the Chinese medicinal herb, thunder god vine. Molecules. 2011;16(6):5283-97. DOI |
23 | Tan W, Lu J, Huang M, Li Y, Chen M, Wu G, et al. Anti-cancer natural products isolated from chinese medicinal herbs. Chin Med. 2011;6(1):27:1-15. DOI |
24 | Stasiak N, Kukula-Koch W, Glowniak K. Modern industrial and pharmacological applications of indigo dye and its derivatives-a review. Acta Pol Pharm. 2014;71(2):215-21. |
25 | State Pharmacopoeia Commission of the PRC. Pharmacopoeia of the People's Republic of China. China: People's Medical Publishing House; 2005. |
26 | Tang W., Eisenbrand G. Chinese Drugs of Plant Origin: Chemistry, Pharmacology, and Use in Traditional and Modern Medicine. Berlin: Springer-Verlag; 1992. |
27 | Han J. Traditional Chinese medicine and the search for new antineoplastic drugs. J Ethnopharmacol. 1988;24(1):1-17. DOI |
28 | Yang MH, Wan WQ, Luo JS, Zheng MC, Huang K, Yang LH, et al. Multicenter randomized trial of arsenic trioxide and Realgar-Indigo naturalis formula in pediatric patients with acute promyelocytic leukemia: Interim results of the SCCLG-APL clinical study. Am J Hematol. 2018;93(12):1467-73. DOI |
29 | Cao Z, Yang F, Wang J, Gu Z, Lin S, Wang P, et al. Indirubin Derivatives as Dual Inhibitors Targeting Cyclin-Dependent Kinase and Histone Deacetylase for Treating Cancer. J Med Chem. 2021;64(20):15280-96. DOI |
30 | Liau BC, Jong TT, Lee MR, Chen SS. LC-APCI-MS method for detection and analysis of tryptanthrin, indigo, and indirubin in daqingye and banlangen. J Pharm Biomed Anal. 2007;43(1):346-51. DOI |
31 | Gao W, Guo Y, Wang C, Lin Y, Yu L, Sheng T, et al. Indirubin ameliorates dextran sulfate sodium-induced ulcerative colitis in mice through the inhibition of inflammation and the induction of Foxp3-expressing regulatory T cells. Acta Histochem. 2016;118(6):606-14. DOI |
32 | Nam S, Buettner R, Turkson J, Kim D, Cheng JQ, Muehlbeyer S, et al. Indirubin derivatives inhibit Stat3 signaling and induce apoptosis in human cancer cells. Proc Natl Acad Sci U S A. 2005;102(17):5998-6003. DOI |
33 | Wang H, Wang Z, Wei C, Wang J, Xu Y, Bai G, et al. Anticancer potential of indirubins in medicinal chemistry: Biological activity, structural modification, and structure-activity relationship. Eur J Med Chem. 2021;223:113652:1-30. |
34 | Hsieh WL, Lin YK, Tsai CN, Wang TM, Chen TY, Pang JH. Indirubin, an acting component of indigo naturalis, inhibits EGFR activation and EGF-induced CDC25B gene expression in epidermal keratinocytes. J Dermatol Sci. 2012;67(2):140-6. DOI |
35 | Ru J, Li P, Wang J, Zhou W, Li B, Huang C, et al. TCMSP: a database of systems pharmacology for drug discovery from herbal medicines. J Cheminform. 2014;6:13:1-6. DOI |
36 | Lin YK, Chang SH, Yang CY, See LC, Lee BH, Shih IH. Efficacy and safety of indigo naturalis ointment in Treating Atopic Dermatitis: A randomized clinical trial. J Ethnopharmacol. 2020;250:112477:1-8. |
37 | Kaur R, Manjal SK, Rawal RK, Kumar K. Recent synthetic and medicinal perspectives of tryptanthrin. Bioorg Med Chem. 2017;25(17):4533-52. DOI |
38 | Chiang YR, Li A, Leu YL, Fang JY, Lin YK. An in vitro study of the antimicrobial effects of indigo naturalis prepared from Strobilanthes formosanus Moore. Molecules. 2013;18(11):14381-96. DOI |
39 | Daina A, Michielin O, Zoete V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep. 2017;7:42717:1-13. |
40 | Zhou Y, Zhou B, Pache L, Chang M, Khodabakhshi AH, Tanaseichuk O, et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun. 2019;10(1):1523:1-10. DOI |
41 | Liu SG, Luo GP, Qu YB, Chen YF. Indirubin inhibits Wnt/beta-catenin signal pathway via promoter demethylation of WIF-1. BMC Complement Med Ther. 2020;20(1):250:1-10. DOI |
42 | Hoessel R, Leclerc S, Endicott JA, Nobel ME, Lawrie A, Tunnah P, et al. Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinases. Nat Cell Biol. 1999;1(1):60-7. DOI |
43 | Premanathan M, Radhakrishnan S, Kulangiappar K, Singaravelu G, Thirumalaiarasu V, Sivakumar T, et al. Antioxidant & anticancer activities of isatin (1H-indole-2,3-dione), isolated from the flowers of Couroupita guianensis Aubl. Indian J Med Res. 2012;136(5):822-6. |
![]() |